486Meropenem and Piperacillin-tazobactam have Comparable Outcomes in Treatment of Bloodstream Infections Caused by Extended Spectrum Beta-lactamase Producing E.coli and Klebsiellae | Zendy

Patrick N. A. Harris | Zendy; Yin Mo | Zendy; Roland Jureen | Zendy; Jonathan Chew | Zendy; Jaminah Ali | Zendy; David L. Paterson | Zendy; Paul Anantharajah Tambyah | Zendy

Open Access

486Meropenem and Piperacillin-tazobactam have Comparable Outcomes in Treatment of Bloodstream Infections Caused by Extended Spectrum Beta-lactamase Producing E.coli and Klebsiellae

Author(s) -

Patrick N. A. Harris,

Yin Mo,

Roland Jureen,

Jonathan Chew,

Jaminah Ali,

David L. Paterson,

Paul Anantharajah Tambyah

Publication year - 2014

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofu052.352

Subject(s) - piperacillin/tazobactam , medicine , piperacillin , tazobactam , beta lactamase , microbiology and biotechnology , beta (programming language) , beta lactamase inhibitors , beta lactam , antibiotics , broad spectrum , intensive care medicine , escherichia coli , bacteria , imipenem , antibiotic resistance , biology , pseudomonas aeruginosa , biochemistry , chemistry , genetics , combinatorial chemistry , gene , computer science , programming language

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research